The Fate of Pro-TNF-α Following Inhibition of Metalloprotease-Dependent Processing to Soluble TNF-α in Human Monocytes

Journal of Immunology

Volumn 159, Issue 9, 1997, Pages 4524-4531

  Solomon, Kimberly A ^a   Covington, Maryanne B ^a   DeCicco, Carl P ^a   Newton, Robert C ^a,b  

^a DUPONT COMPANY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; METALLOPROTEINASE; PROTEIN PRECURSOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; MONOCYTE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL MEMBRANE; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; LIPOPOLYSACCHARIDES; METALLOENDOPEPTIDASES; MONOCYTES; PROTEIN PRECURSORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031278428     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Aggarwal, B. B., and K. Natarajan. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:93.
2. Weinberger, M. S., T. M. Davidson, and D. H. Broide. 1996. Differential expression of vascular cell adhesion molecule mRNA and protein in nasal mucosa in response to IL-1 or tumor necrosis factor. J. Allergy Clin. Immunol. 97:662.
3. Bedard, P. A., and E. E. Golds. 1993. Cytokine-induced expression of mRNAs for chemotactic factors in human synovial cells and fibroblasts. J. Cell. Physiol. 154:433.
4. Feldmann, M., M. J. Elliott, F. M. Brennan, and R. N. Maini. 1994. Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis. J. Interferon Res. 14:299.
5. Elliott, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breedveld, J. D. Macfarlane, H. Bijl, and J. N. Woody. 1994. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105.
6. Elliott, M. J., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, H. Bijl, and J. N. Woody. 1994. Repeated therapy with monoclonal antibody to tumor necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 344:1125.
7. Van Dullemen, H. M., S. J. H. Van Deventer, D. W. Hommes, H. A. Bijl, J. Jansen, G. N. J. Tytgat, and J. Woody. 1995. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:129.
8. Lorenz, H. M., C. Antoni, T. Valerius, R. Repp, M. Grunke, N. Schwerdtner, H. Nublein, J. Woody, J. R. Kalden, and B. Manger. 1996. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis. J. Immunol. 156:1646.
9. Issekutz, A. C., A. Meager, I. Otterness, and T. B. Issekutz. 1994. The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis. Clin. Exp. Immunol. 97:26.
10. Piguet, P. F., G. E. Grau, C. Hauser, and P. Vassalli. 1991. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J. Exp. Med. 173:673.
11. Baker, D., D. Butler, B. J. Scallon, J. K. O'Neill, J. L. Turk, and M. Feldmann. 1994. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24:2040.
12. Gearing, A. J. H., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. M. Wood, and K. Woolley. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555.
13. McGeehan, G. M., J. D. Becherer, R. C. Bast, Jr., C. M. Boyer, B. Champion, K. M. Connolly, J. G. Conway, P. Furdon, S. Karp, S. Kidao, A. B. McElroy, J. Nichols, K. M. Pryzwansky, F. Schoenen, L. Sekut, A. Truesdale, M. Verghese, J. Warner, and J. P. Ways. 1994. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370:558.
14. Moss, M. L., S. L. C. Jin, M. E. Milla, W. Burkhart, H. L. Carter, W. J. Chen, W. C. Clay, J. R. Didsbury, D. Hassler, C. R. Hoffman, T. A. Kost, M. H. Lambert, M. A. Leesnitzer, P. McCauley, G. McGeehan, J. Mitchell, M. Moyer, G. Pahel, W. Rocque, L. K. Overton, F. Schoenen, T. Seaton, J. L. Su, J. Warner, D. Willard, and J. D. Becherer. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385: 733.
15. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slcak, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Bolani, K. A. Schooley, M. Gerhart, R. Davis, J. N. Fitzner, R. S. Johnson, R. J. Paxton, C. J. March, and D. P. Cerretti. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729.
16. Kriegler, M., C. Perez, K. DeFay, I. Albert, and S. D. Lu. 1988. A novel form of TNF/cachetin is a cell surface cytotoxic transmembrane protein: ramification for the complex physiology of TNF. Cell 53:45.
17. Kinkhabwala, M., P. Sehajpal, E. Skolnik, D. Smith, V. K. Shrma, H. Vlassara, A. Cerami, and M. Suthanthiran. 1990. A novel addition to the T cell repertory: cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J. Exp. Med. 171:941.
18. Keffer, J., L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, and G. Kollias. 1991. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J. 10:4025.
19. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.
20. Newton, R. C. 1986. Human monocyte production of interleukin-1: parameters of the induction of interleukin-1 secretion by lipopolysaccharides. J. Leukocyte Biol. 39:299.
21. Beckett, R. P., A. H. Davidson, A. H. Drummond, P. Huxley, and M. Whittaker. 1996. Recent advances in matrix metalloproteinase inhibitor research. Drug Dev. Today 1:16.
22. Zagursky, R. J., D. Sharp, K. A. Solomon, and A. Schwartz. 1995. Quantitation of cellular receptors by a new immunocytochemical flow cytometry technique. Biotechniques 18:504.
23. Schwartz, A., and E. Fernandez-Repollet. 1994. Standardization for flow cytometry. In Flow Cytometry, Vol. B. Z. Darzynkiewicz, J. P. Robinson, and H. A. Crissman, eds. Academic Press, New York, pp. 605-626.
24. Bouma, M. G., R. K. Stad, F. A. J. M. van den Wildenberg, and W. A. Buurman. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:4159.
25. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
26. Hooper, N. M. 1994. Families of zinc metalloproteases. FEBS Lett. 354:1.
27. Huovila, A. P. J., E. A. C. Almeida, and J. M. White. 1996. ADAMS and cell fusion. Curr. Opin. Cell Biol. 8:692.
28. Robache-Gallea, S., V. Morand, J. M. Bruneau, B. Schoot, E. Tagat, E. Realo, S. Chouaib, and S. Roman-Roman. 1995. In vitro processing of human tumor necrosis factor-α. J. Biol. Chem. 270:23688.
29. Perez, C., I. Albert, K. DeFay, N. Zachariades, L. Gooding, and M. Kriegler. 1990. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63:251.
30. + T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177:1575.
31. Holgate, S. T. 1996. The immunopharmacology of mild asthma. J Allergy Clin. Immunol. 98:S7.
32. Crowe, P. D., B. N. Walter, K. M. Mohler, C. Otten-Evans, R. A. Black, and C. F. Ware. 1995. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181:1205.
33. Minami, Y., A. M. Weissman, L. E. Samelson, and R. D. Klausner. 1987. Building a multichain receptor: synthesis, degradation and assembly of the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 84:2688.
34. Deng, J., V. Rudick, and L. Dory. 1996. Lysosomal degradation and sorting of apolipoprotein E in macrophages. J. Lipid Res. 36:2129.
35. Pocsik, E., E. Duda, and D. Wallach. 1995. Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. J. Inflamm. 45:152.
36. Yewdell, J. W., and J. R. Bennink. 1989. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Science 244:1072.
37. Lunn, C. A., X. Fan, B. Dalie, K. Miller, P. J. Zavodny, S. K. Narula, and D. Lundell. 1997. Purification of ADAM 10 from bovine spleen as a TNFα convertase. FEBS Lett. 400:333.
38. Gijbels, K., R. E. Galardy, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94:2177.
39. Mohler, K. M., P. R. Sleath, J. N. Fitzner, D. P. Cerretti, M. Alderson, S. S. Kerwar, D. S. Torrance, C. Otten-Evans, T. Greenstreet, K. Weerawarna, S. R. Kronheim, M. Petersen, M. Gerhart, C. J. Kozlosky, C. J. March, and R. A. Black. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370:218.
40. Conway, J. G., J. A. Wakefield, R. H. Brown, B. E. Marron, L. Sekut, S. A. Stimpson, A. McElroy, J. A. Menius, J. J. Jeffreys, R. L. Clark, G. M. McGeehan, and K. M. Connolly. 1995. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J. Exp. Med. 182:449.
41. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. F. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Deceased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560.
42. Solorzano, C. C., R. Ksontini, J. H. Pruitt, P. J. Hess, P. D. Edwards, A. Kaibara, A. Abouhamze, T. Auffenberg, R. E. Galardy, J. N. Vauthey, E. M. Copeland III, C. K. Edwards III, G. Y. Lauwers, M. Clare-Salzler, S. L. D. MacKay, L. L. Moldawer, and D. D. Lazarus. 1997. Involvement of 26-kDa cell-associated TNF-α in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J. Immunol. 158:414.